Boots Healthcare International is hiring former Kellogg’s marketing chief Rob Morgan as its director of marketing.
Morgan, who has worked as managing director of car accessories company Turtle Wax International for the past year, takes up the post after Christmas.
He replaces Peter Milburn, who has been moved by parent company Boots to act as director of marketing for its Japanese operation (MW November 15).
The operation will test store openings in Japan in conjunction with a joint-venture partner, which is yet to be announced.
Morgan left Kellogg in November last year after working for the company for four years, and took up the managing director’s position at US company Turtle Wax. The move surprised some observers as it was a switch away from mainstream UK packaged goods marketing.
At BHI, Morgan will oversee marketing for the company’s three international divisions: analgesics which includes the Nurofen brand; the coughs and throats division, including Strepsils (headed by former Carlsberg-Tetley marketing director Liz Morgan); and skincare, which covers the E45 brand and two new products. These are Lutsine and Onagrine and were added to the portfolio after the acquisition of French company Lutsia.
Morgan will be on the board of BHI and report to managing director Barry Clare.